Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA accepts the biologics license application for Avelumab for the treatment of metastatic urothelia

pharmaasiaMarch 14, 2017

Tag: FDA , metastatic urothelial carcinoma

PharmaSources Customer Service